HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donna M Platt Selected Research

Triazolam (Halcion)

1/20218-Substituted Triazolobenzodiazepines: In Vitro and In Vivo Pharmacology in Relation to Structural Docking at the α1 Subunit-Containing GABAA Receptor.
11/2002Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Donna M Platt Research Topics

Disease

6Ataxia (Dyssynergia)
11/2021 - 11/2002
4Cocaine-Related Disorders (Cocaine Addiction)
10/2008 - 10/2002
2Pain (Aches)
01/2022 - 01/2017
2Substance-Related Disorders (Drug Abuse)
01/2022 - 12/2011
2Alcoholism (Alcohol Abuse)
11/2010 - 06/2010
2Catalepsy
09/2009 - 03/2003
1Pruritus (Itching)
01/2022
1Shock
01/2021
1Tremor (Tremors)
04/2020
1Seizures (Absence Seizure)
04/2014
1Huntington Disease (Huntington's Disease)
03/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2014
1Muscle Rigidity
03/2003

Drug/Important Bio-Agent (IBA)

4Alprazolam (Xanax)FDA LinkGeneric
11/2021 - 08/2006
3Cocaine (Cocaine HCl)IBA
11/2007 - 10/2002
2Triazolam (Halcion)FDA LinkGeneric
01/2021 - 11/2002
2Flumazenil (Romazicon)FDA LinkGeneric
04/2020 - 11/2002
2Zolpidem (Ambien)FDA LinkGeneric
01/2018 - 11/2002
2mu Opioid Receptors (mu Opioid Receptor)IBA
01/2017 - 06/2010
2Dopamine (Intropin)FDA LinkGeneric
03/2014 - 11/2007
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
01/2022
1Midazolam (Versed)FDA LinkGeneric
11/2021
1Anti-Anxiety Agents (Anxiolytics)IBA
01/2021
1Dimenhydrinate (DMH)FDA LinkGeneric
01/2021
1Hypnotics and Sedatives (Sedatives)IBA
01/2020
18- ethynyl- 6- (2'- pyridine)- 4H- 2,5,10b- triazabenzo(e)azulene- 3- carboxylic acid ethyl esterIBA
01/2018
17- (1,1- dimethylethyl)- 6- (2- ethyl- 2H- 1,2,4- triazol- 3- ylmethoxy)- 3- (2- fluorophenyl)- 1,2,4- triazolo(4,3- b)pyridazineIBA
01/2018
1Diazepam (Valium)FDA LinkGeneric
01/2018
1Sucrose (Saccharose)IBA
04/2014
1N-Methylaspartate (NMDA)IBA
03/2014
1Neurotransmitter Agents (Neurotransmitter)IBA
03/2014
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
03/2014
1GABA-A Receptors (GABA(A) Receptor)IBA
11/2010
1Carbolines (Beta-Carbolines)IBA
11/2010
1gamma-Aminobutyric Acid (GABA)IBA
11/2010
1LigandsIBA
11/2010
1Naltrexone (ReVia)FDA LinkGeneric
06/2010
1N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)butyl)- 4- (pyridin- 2- yl)benzamideIBA
09/2009
1Opioid Analgesics (Opioids)IBA
11/2007
1zaleplon (Sonata)FDA LinkGeneric
08/2006
16- fluoro- 9- methyl- 2- phenyl- 4- (pyrrolidin- 1- yl- carbonyl)- 2,9- dihydro- 1H- pyrido(3,4- b)indol- 1- oneIBA
06/2005
1nemonaprideIBA
03/2003
1dironyl (terguride)IBA
03/2003
1tert-butyl beta-carboline-3-carboxylateIBA
11/2002

Therapy/Procedure

4Drug Therapy (Chemotherapy)
10/2008 - 10/2002
3Deep Sedation
11/2021 - 01/2018
1Conscious Sedation
01/2018
1Self Administration (Administration, Self)
12/2011